Hanall, Yungjin listed in MSCI index

Published: 2009-05-18 06:58:00
Updated: 2009-05-18 06:58:00
Hanall Pharm and Yungjin Pharm have recently been included in the list of Morgan Stanley Capital International (MSCI) South Korea Index to gauge shares valued $100 million, according to an analyst of Daewoo Securities.

He said that such new listing will give them the potential to attract more ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.